StockData
Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc. (NRIX) stock

NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 13, 2026Score 15/3073% below fair value
$14.24−0.49 (-3.33%)

Close on Nov 17, 2026Market cap $1.56BP/E 6.2Yield 0.00%

Nurix Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nurix Therapeutics's revenue for the twelve months ending Aug 31, 2026 was $701.94M, up 738.8% year over year. For fiscal 2025 it was $83.98M, up 54.0% from the year before. The highest annual figure on record is $83.98M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Nov 30, 2025$83.98M+54.0%
FY2024Nov 30, 2024$54.55M-29.1%
FY2023Nov 30, 2023$76.99M+99.3%
FY2022Nov 30, 2022$38.63M+29.8%
FY2021Nov 30, 2021$29.75M+66.9%
FY2020Nov 30, 2020$17.82M-42.7%
FY2019Nov 30, 2019$31.12M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$673.06M+8426.3%
Q2 FY2026CQ2 2026May 31, 2026$9.04M-79.5%
Q1 FY2026CQ1 2026Feb 28, 2026$6.25M-66.1%
Q4 FY2025CQ4 2025Nov 30, 2025$13.58M+2.2%
Q3 FY2025CQ3 2025Aug 31, 2025$7.89M-37.3%
Q2 FY2025CQ2 2025May 31, 2025$44.06M+264.3%
Q1 FY2025CQ1 2025Feb 28, 2025$18.45M+11.3%
Q4 FY2024CQ4 2024Nov 30, 2024$13.28M-12.4%
Q3 FY2024CQ3 2024Aug 31, 2024$12.59M-31.8%
Q2 FY2024CQ2 2024May 31, 2024$12.09M-60.6%
Q1 FY2024CQ1 2024Feb 29, 2024$16.59M+30.7%
Q4 FY2023CQ4 2023Nov 30, 2023$15.16M+123.5%
Q3 FY2023CQ3 2023Aug 31, 2023$18.47M+71.1%
Q2 FY2023CQ2 2023May 31, 2023$30.68M+168.3%
Q1 FY2023CQ1 2023Feb 28, 2023$12.69M+31.8%
Q4 FY2022CQ4 2022Nov 30, 2022$6.78M-8.3%
Q3 FY2022CQ3 2022Aug 31, 2022$10.79M+5.3%
Q2 FY2022CQ2 2022May 31, 2022$11.43M+61.2%
Q1 FY2022CQ1 2022Feb 28, 2022$9.62M+92.0%
Q4 FY2021CQ4 2021Nov 30, 2021$7.40M+10.6%
Q3 FY2021CQ3 2021Aug 31, 2021$10.25M+151.0%
Q2 FY2021CQ2 2021May 31, 2021$7.09M+69.6%
Q1 FY2021CQ1 2021Feb 28, 2021$5.01M+75.0%
Q4 FY2020CQ4 2020Nov 30, 2020$6.69M+259.2%
Q3 FY2020CQ3 2020Aug 31, 2020$4.09M-61.4%
Q2 FY2020CQ2 2020May 31, 2020$4.18M-55.7%
Q1 FY2020CQ1 2020Feb 29, 2020$2.86M-69.0%
Q4 FY2019CQ4 2019Nov 30, 2019$1.86M–
Q3 FY2019CQ3 2019Aug 31, 2019$10.58M–
Q2 FY2019CQ2 2019May 31, 2019$9.44M–
Q1 FY2019CQ1 2019Feb 28, 2019$9.23M–

More Nurix Therapeutics figures

See a number that looks wrong?